ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Flagship Pioneering, Inc.
This hands-on laboratory role focuses on expanding protein production capabilities across bulk expression and high-throughput parallel production scales. The position involves executing scalable workflows for protein expression, purification, normalization, and characterization to support the company's design-build-test cycles. The successful candidate will collaborate with cross-functional teams to deliver well-characterized protein reagents on rapid timelines while troubleshooting technical challenges.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Founded
2000
Flagship Pioneering is a venture creation and investment firm that invents, builds, and funds early-stage companies in biotechnology, life sciences, and sustainability. Using an integrated model of in-house science, lab infrastructure, capital, and operational support, it spins out and scales breakthrough ventures — it has helped found more than 100 companies, including high-profile names such as Moderna. Flagship focuses on deep‑science innovation and long‑term partnerships to translate novel discoveries into transformative products for human health and the planet.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Flagship Pioneering, Inc..
Right around the average for this role
individual investors who own 52% along with institutions invested in Seres Therapeutics, Inc. (NASDAQ:MCRB) saw increase in their holdings value last week
Jul 20, 2025
Scientist, High-Throughput Protein Expression and Purification
Bristol Myers Squibb
Molecular Biology Intern
Adaptyv Bio
Senior Principal Research Scientist, Protein Sciences
IDEAYA Biosciences, Inc.
Protein Science
proteros
Associate Scientist - Recombinant Protein Development
Revvity
Senior Scientist I
Generate:Biomedicines
